How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery?

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 3, 2009, Pages 260.e1-260.e3

  Creasman, William T ^a   Kohler, Matthew ^a   Korte, Jeffrey E ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

cervical cancer; prognostic factor

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; HUMAN; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; RECURRENCE RISK; RISK FACTOR; UTERINE CERVIX CANCER; VALIDITY;

EID: 69349093138     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.04.020     Document Type: Article

References (5)

1. Creasman W.T., and Kohler M.F. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer?. Gynecol Oncol 92 (2004) 525-529
2. Sedlis A., Bundy B.N., Rotman M.Z., et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy. Gynecol Oncol 73 (1999) 177-183
3. Rotman M., Sedlis A., Piedmonte M.R., et al. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features. Int J Radiat Oncol Biol Phys 65 (2006) 169-176
4. Delgado G., Bunch B., Zaino R., et al. Prospective surgical pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix. Gynecol Oncol 38 (1990) 352-357
5. Peters W.A., Liu P.Y., Barrett R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation alone as adjuvant therapy after radical surgery in high risk early stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613